Summit Global Investments Pacira Bio Sciences, Inc. Transaction History

Summit Global Investments

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$36.12 - $47.5 $290,549 - $382,090	8,044 New	8,044 $322,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $230,580 - $265,005	4,500 Added 27.44%	20,900 $1.11 Million
Q2 2022 Aug 23, 2022	BUY	$51.49 - $81.64 $66,937 - $106,132	1,300 Added 8.61%	16,400 $956,000
Q1 2022 Apr 29, 2022	SELL	$60.03 - $76.49 $948,474 - $1.21 Million	-15,800 Reduced 51.13%	15,100 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $614,016 - $796,288	12,800 Added 70.72%	30,900 $1.86 Million
Q3 2021 Nov 08, 2021	BUY	$54.64 - $61.3 $988,984 - $1.11 Million	18,100 New	18,100 $1.01 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.